Transforming medicine through non-viral gene therapy, Theresa Heah, CEO, Intergalactic Tx
Synopsis: Theresa Heah, M.D., is the CEO of Intergalactic Therapeutics. Intergalactic is overcoming the limitations of viral-based gene therapy and developing a best-in-class non-viral alternative. I...
2 Elo 202319min
Transforming diseased cells into coordinators of cure, Volker Herrmann, President & CEO, Sonata Tx
Synopsis: Volker Herrmann is the President and CEO of Sonata Therapeutics, a Flagship Pioneering company revolutionizing the world’s understanding of the cellular microenvironment and its importance...
26 Heinä 202334min
Breaking barriers in rare genetic mitochondrial diseases, Greg Flesher, Pres. & CEO, Reneo
Synopsis: Greg Flesher is the President and CEO of Reneo Pharmaceuticals, a clinical-stage pharmaceutical company focused on the development of therapies for patients with rare genetic mitochondrial...
19 Heinä 202327min
Correcting abnormal gene expression in oncology, Adrian Gottschalk, Pres. & CEO, Foghorn Tx
Synopsis: Adrian Gottschalk is the president and CEO of Foghorn Therapeutics, a clinical-stage biotechnology company pioneering a new class of medicines that treat cancers and other serious diseases...
12 Heinä 202331min
Epigenetic therapies for organ injury & chronic liver diseases, Jim Brown, Pres. & CEO, DURECT
Synopsis: Jim Brown is the President and CEO of DURECT Corporation, a biopharmaceutical company committed to transforming the treatment of acute organ injuries and chronic liver diseases by advancin...
5 Heinä 202329min
New vision for preventing & curing age-related diseases, James Peyer, Founder & CEO, Cambrian Bio
Synopsis: James Peyer, Ph.D., is the Founder and CEO of Cambrian Bio, a clinical-stage drug-development company focused on creating therapies to prevent and cure age-related diseases. James discusses...
28 Kesä 202329min
Revolutionizing T-cells for solid tumor cell therapies, Gary Lee, CSO, Lyell Immunopharma
Synopsis: Gary Lee, Ph.D. is the CSO of Lyell Immunopharma, a T-cell reprogramming company dedicated to developing cell therapies for patients with solid tumors. A chemical engineer by training, Gar...
21 Kesä 202328min
Mobilizing the immune system to combat disease, Liang Schweizer, Founder & CEO, HiFiBiO Tx
Synopsis: Liang Schweizer, Ph.D. is the Founder and CEO of HiFiBiO Therapeutics, a clinical-stage global biotech company mobilizing the human immune system to combat disease. The company employs its...
14 Kesä 202330min
